Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

Denise G. O’Mahony, Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John, Ute Hamann, Evgeny N. Imyanitov, Irene L. Andrulis, Priyanka Sharma, Mary B. Daly, Christopher R. Hake, Jeffrey N. Weitzel, Anna Jakubowska, Andrew K. Godwin, Adalgeir Arason, Anita Bane, Jacques Simard, Penny Soucy, Maria A. CaligoPhuong L. Mai, Kathleen B.M. Claes, Manuel R. Teixeira, Wendy K. Chung, Conxi Lazaro, Peter J. Hulick, Amanda E. Toland, Inge Sokilde Pedersen, HEBON Investigators, Marian J.E. Mourits (Medlem af forfattergruppering), Susan L. Neuhausen, Ana Vega, Miguel de la Hoya, Heli Nevanlinna, Mallika Dhawan, Valentina Zampiga, Rita Danesi, Liliana Varesco, Viviana Gismondi, Valerio Gaetano Vellone, Paul A. James, Ramunas Janavicius, Liene Nikitina-Zake, Finn Cilius Nielsen, Thomas van Overeem Hansen, Tanja Pejovic, Ake Borg, Johanna Rantala, Kenneth Offit, Marco Montagna, Katherine L. Nathanson, Susan M. Domchek, Ana Osorio, María J. García, Beth Y. Karlan, GEMO Study Collaborators, Fabienne Lesueur (Medlem af forfattergruppering), Anna De Fazio, David Bowtell (Medlem af forfattergruppering), AOCS Group, Anna De Fazio (Medlem af forfattergruppering), Lesley McGuffog, Goska Leslie, Michael T. Parsons, Thilo Dörk, Lisa Marie Speith, Elizabeth Santana dos Santos, Alexandre André B.A. da Costa, Paolo Radice, Paolo Peterlongo, Laura Papi, Christoph Engel, Eric Hahnen, Rita K. Schmutzler, Barbara Wappenschmidt, Douglas F. Easton, Marc Tischkowitz, Christian F. Singer, Yen Yen Tan, Alice S. Whittemore, Weiva Sieh, James D. Brenton, Drakoulis Yannoukakos, Florentia Fostira, Irene Konstantopoulou, Jana Soukupova (Medlem af forfattergruppering), Michal Vocka (Medlem af forfattergruppering), CZECANCA Consortium, Georgia Chenevix-Trench, Paul D.P. Pharoah, Antonis C. Antoniou, David E. Goldgar, Amanda B. Spurdle, Kyriaki Michailidou^*, Miguel de la Hoya, Thomas van Overeem Hansen, Elizabeth Santana dos Santos, The Consortium of Investigators of Modifiers of BRCA1/2, Evidence-based Network for the Interpretation of Germline Mutant Alleles ConsortiumVis 79 andreVis mindre